Skip to content

Clinical trials

Phase 2 Anemia trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anemia Phase: Phase 2 Country / region: Russia Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20081
20091
20101
20111
20132
20161
20172
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline4
Affymax1
Biocad1
Kezar Life Sciences, Inc.1
Kyntra Bio1
Merck Sharp & Dohme LLC1
Novartis Pharmaceuticals1
University of Bergen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anemia11
Renal Insufficiency, Chronic4
Anemia, Hemolytic, Autoimmune2
Hemolysis2
Kidney Failure, Chronic2
Hematologic Diseases1
Kidney Diseases1
Lymphoproliferative Disorders1
Neoplasm Metastasis1
Neoplasms1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.